Bionevia

BioNevia is a specialty biotechnology company focused on the discovery and development of therapies for rare and neglected diseases, commonly known as orphan diseases. The company utilizes a proprietary platform to identify and rescue drug candidates that have stalled in development, aiming to repurpose them for indications with high unmet medical needs. BioNevia's portfolio primarily targets rare metabolic disorders and specific oncology segments, leveraging deep data analytics to streamline the drug development process. Led by Dr. Michael Kinch, the company integrates academic research insights with commercialization strategies to accelerate the delivery of orphan drugs to patients. BioNevia operates as a private entity, maintaining strategic collaborations to advance its early-stage pipeline.